Evidence map›Paper›PMID 31867283›Full record

ReviewFrontiers in cellular and infection microbiology2019

Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.

Shahram Solaymani-Mohammadi, Lars Eckmann, Steven M Singer

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immune modulation of Th1/Th2/Treg/Th17/Th9/Th21 cells in rabbits infected withFrontiers in cellular and infection microbiology · 2023
    Article
  8. Review
  9. Role of NK-Like CD8Infection and immunity · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. How the gut parasitome affects human health.Therapeutic advances in gastroenterology · 2022
    Review
  15. Immunosuppression in Malaria: DoPathogens (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Shahram Solaymani-MohammadiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Lars EckmannDepartment of Medicine, University of California, San Diego, La Jolla, CA, United States.
Steven M SingerDepartment of Biology, Georgetown University, Washington, DC, United States.
Georgetown University · USInfectious Disease Research Institute · USUniversity of California, San Diego · US

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
The Role of Macrophages in Immune Responses to GiardiaR15AI109591 · NIAID · GEORGETOWN UNIVERSITY · PI SINGER, STEVEN M · 2014 to 2023
$1.5M
NIAID NIH HHS R15 AI109591NIDDK NIH HHS P30 DK120515
6 · The paper itself

Abstract

Parasitic diseases cause significant morbidity and mortality in the developing and underdeveloped countries. No efficacious vaccines are available against most parasitic diseases and there is a critical need for developing novel vaccine strategies for care. IL-21 is a pleiotropic cytokine whose functions in protection and immunopathology during parasitic diseases have been explored in limited ways. IL-21 and its cognate receptor, IL-21R, are highly expressed in parasitized organs of infected humans as well in murine models of the human parasitic diseases. Prior studies have indicated the ability of the IL-21/IL-21R signaling axis to regulate the effector functions (e.g., cytokine production) of T cell subsets by enhancing the expression of T-bet and STAT4 in human T cells, resulting in an augmented production of IFN-γ. Mice deficient for either IL-21 (

Indexed as

Disease SusceptibilityImmunityAnimalsGene Expression RegulationHumansInflammationInterleukin-21Interleukin-21 Receptor alpha SubunitInterleukinsParasitic DiseasesSignal TransductionIL21R protein, humanInterleukin-21Interleukin-21 Receptor alpha SubunitInterleukinscytokineimmunityinflammationinterleukin (IL)-21parasitesignaling

Identifiers

PMID31867283
PMCPMC6904299
OpenAlexW2992630846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.